{"entity":{"type":"insider","cik":"0001918033","url":"/insider/0001918033","json_url":"/insider/0001918033.json","name":"Eydelman Mikhail","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":59,"n_filings":18,"first":"2023-10-04","last":"2025-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Eydelman Mikhail","source":"filing","n_filings":18,"first_seen":"2023-10-04","last_seen":"2025-03-07"}],"transactions":[{"id":4774475,"accession":"0001649094-25-000045","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001649094-25-000045","line_url":"/filing/0001649094-25-000045","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":70.739802,"price_display":"70.74","price_state":"stated","total_value":353699.01,"total_display":"353,699.01","total_whole":"353,699","shares_owned_after":43999.0,"shares_owned_after_display":"43,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider","n_lines":3},{"id":4742704,"accession":"0001649094-25-000012","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001649094-25-000012","line_url":"/filing/0001649094-25-000012","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":90.073728,"price_display":"90.07","price_state":"stated","total_value":450368.64,"total_display":"450,368.64","total_whole":"450,369","shares_owned_after":28477.0,"shares_owned_after_display":"28,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-07","scope":"insider","n_lines":5},{"id":4096814,"accession":"0001649094-25-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001649094-25-000004","line_url":"/filing/0001649094-25-000004","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.5845592,"price_display":"85.58","price_state":"stated","total_value":427922.796,"total_display":"427,922.80","total_whole":"427,923","shares_owned_after":28347.0,"shares_owned_after_display":"28,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider","n_lines":3},{"id":2923387,"accession":"0001649094-24-000118","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001649094-24-000118","line_url":"/filing/0001649094-24-000118","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":91.4867834,"price_display":"91.49","price_state":"stated","total_value":457433.917,"total_display":"457,433.92","total_whole":"457,434","shares_owned_after":29085.0,"shares_owned_after_display":"29,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-09","scope":"insider","n_lines":3},{"id":2491755,"accession":"0001649094-24-000099","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001649094-24-000099","line_url":"/filing/0001649094-24-000099","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":106.3606724,"price_display":"106.36","price_state":"stated","total_value":531803.362,"total_display":"531,803.36","total_whole":"531,803","shares_owned_after":29896.0,"shares_owned_after_display":"29,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-06","scope":"insider","n_lines":4},{"id":2830796,"accession":"0001649094-24-000079","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001649094-24-000079","line_url":"/filing/0001649094-24-000079","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":109.2705102,"price_display":"109.27","price_state":"stated","total_value":546352.551,"total_display":"546,352.55","total_whole":"546,353","shares_owned_after":29004.0,"shares_owned_after_display":"29,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-07","filed_date":"2024-10-08","scope":"insider","n_lines":5},{"id":2745714,"accession":"0001649094-24-000075","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001649094-24-000075","line_url":"/filing/0001649094-24-000075","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":114.23541054545454,"price_display":"114.24","price_state":"stated","total_value":628294.758,"total_display":"628,294.76","total_whole":"628,295","shares_owned_after":29653.0,"shares_owned_after_display":"29,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider","n_lines":3},{"id":2614195,"accession":"0001649094-24-000062","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001649094-24-000062","line_url":"/filing/0001649094-24-000062","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":112.1052903419316,"price_display":"112.11","price_state":"stated","total_value":186879.519,"total_display":"186,879.52","total_whole":"186,880","shares_owned_after":31251.0,"shares_owned_after_display":"31,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider","n_lines":7},{"id":2745619,"accession":"0001649094-24-000042","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001649094-24-000042","line_url":"/filing/0001649094-24-000042","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":78.85374631073785,"price_display":"78.85","price_state":"stated","total_value":131449.1951,"total_display":"131,449.20","total_whole":"131,449","shares_owned_after":31011.0,"shares_owned_after_display":"31,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider","n_lines":2},{"id":2292920,"accession":"0001649094-24-000028","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001649094-24-000028","line_url":"/filing/0001649094-24-000028","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":76.36711625674864,"price_display":"76.37","price_state":"stated","total_value":127303.9828,"total_display":"127,303.98","total_whole":"127,304","shares_owned_after":31580.0,"shares_owned_after_display":"31,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider","n_lines":2},{"id":2602874,"accession":"0001415889-24-015589","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-015589","line_url":"/filing/0001415889-24-015589","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":72.06191781643672,"price_display":"72.06","price_state":"stated","total_value":120127.217,"total_display":"120,127.22","total_whole":"120,127","shares_owned_after":32077.0,"shares_owned_after_display":"32,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":3},{"id":2069621,"accession":"0001415889-24-012169","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-012169","line_url":"/filing/0001415889-24-012169","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":61.74041511697661,"price_display":"61.74","price_state":"stated","total_value":102921.272,"total_display":"102,921.27","total_whole":"102,921","shares_owned_after":31300.0,"shares_owned_after_display":"31,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider","n_lines":3},{"id":2899292,"accession":"0001415889-24-010001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-010001","line_url":"/filing/0001415889-24-010001","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":66.72713737252549,"price_display":"66.73","price_state":"stated","total_value":111234.138,"total_display":"111,234.14","total_whole":"111,234","shares_owned_after":30867.0,"shares_owned_after_display":"30,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":2},{"id":2743601,"accession":"0001415889-24-006474","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-006474","line_url":"/filing/0001415889-24-006474","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":73.72935812837433,"price_display":"73.73","price_state":"stated","total_value":122906.84,"total_display":"122,906.84","total_whole":"122,907","shares_owned_after":31655.0,"shares_owned_after_display":"31,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider","n_lines":3},{"id":2995438,"accession":"0001415889-24-002613","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-002613","line_url":"/filing/0001415889-24-002613#line-5","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":638.0,"shares_display":"638","price_per_share":73.165,"price_display":"73.16","price_state":"stated","total_value":46679.27,"total_display":"46,679.27","total_whole":"46,679","shares_owned_after":21527.0,"shares_owned_after_display":"21,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":2995436,"accession":"0001415889-24-002613","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-002613","line_url":"/filing/0001415889-24-002613#line-4","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001918033","owner_name":"Eydelman Mikhail","owner_display_name":"Eydelman Mikhail","owner_url":"/insider/0001918033","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark":"O","role_mark_label":"Officer (SVP, GEN COUNSEL & CORP SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GEN COUNSEL & CORP SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":474.0,"shares_display":"474","price_per_share":75.391,"price_display":"75.39","price_state":"stated","total_value":35735.334,"total_display":"35,735.33","total_whole":"35,735","shares_owned_after":20710.0,"shares_owned_after_display":"20,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"}],"collapsed":true,"next_cursor":"2024-02-01|2995436","ledger_fault":false,"count":{"value":59,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":59,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":59},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Officer (SVP, GEN COUNSEL & CORP SEC)","n_filings":18,"first_seen":"2023-10-04","last_seen":"2025-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001918033","retrieved_at":"2026-08-25T20:06:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}